Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid — a population-based analysis

References

• Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Sebaceous carcinoma of the eyelids. Ophthalmology. 2004;111(12):2151–2157. doi:10.1016/j.ophtha.2004.07.031.
   PubMed Web of Science ®Google Scholar
• Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 33(6):477–490. http://www.ncbi.nlm.nih.gov/pubmed/2658172 Accessed July 24, 2017.
   PubMed Web of Science ®Google Scholar
• Wolfe JT, Yeatts RP, Wick MR, Campbell RJ, Waller RR. Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol. 1984;8(8):597–606. http://www.ncbi.nlm.nih.gov/pubmed/6465419 Accessed July 24, 2017.
   PubMed Web of Science ®Google Scholar
• Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms. Cancer. 2008;113(12):3372–3381. doi:10.1002/cncr.23963.
   PubMed Web of Science ®Google Scholar
• Kuzel P, Metelitsa AI, Dover DC, Salopek TG. Epidemiology of sebaceous carcinoma in Alberta, Canada, from 1988 to 2007. J Cutan Med Surg. 2012;16(6):417–423. doi:10.1177/120347541201600610.
   PubMed Web of Science ®Google Scholar
• Bailet JW, Zimmerman MC, Arnstein DP, Wollman JS, Mickel RA. Sebaceous carcinoma of the head and neck. Case report and literature review. Arch Otolaryngol Head Neck Surg. 1992;118(11):1245–1249. http://www.ncbi.nlm.nih.gov/pubmed/1418905 Accessed November 19, 2017.
   PubMedGoogle Scholar
• Berlin AL, Amin SP, Goldberg DJ. Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg. 2008;34(2):254–257. doi:10.1111/j.1524-4725.2007.34051.x.
   PubMed Web of Science ®Google Scholar
• Nelson BR, Hamlet KR, Gillard M, Railan D, Johnson TM. Sebaceous carcinoma. J Am Acad Dermatol. 1995;33(1):1–15; quiz 16–8. http://www.ncbi.nlm.nih.gov/pubmed/7601925 Accessed July 24, 2017. .
   Web of Science ®Google Scholar
• Tryggvason G, Bayon R, Pagedar NA. Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management. Head Neck. 2012;34(12):1765–1768. doi:10.1002/hed.22009.
   PubMed Web of Science ®Google Scholar
• Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115(1):158–165. doi:10.1002/cncr.23952.
   PubMed Web of Science ®Google Scholar
• Kaliki S, Ayyar A, Dave TV, Ali MJ, Mishra DK, Naik MN. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians. Eye. 2015;29(7):958–963. doi:10.1038/eye.2015.79.
   PubMed Web of Science ®Google Scholar
• Zieliński T, Antoszewski B. [Sebaceous carcinoma of the eyelid–two case reports]. Klin Oczna. 2014;116(2):127–129. http://www.ncbi.nlm.nih.gov/pubmed/25345292. Accessed July 24, 2017.
   PubMedGoogle Scholar
• Kaseda K, Ohtsuka T, Hayashi Y, et al. Surgical treatment of a solitary pulmonary metastasis from eyelid sebaceous carcinoma: report of a case. World J Surg Oncol. 2014;12(1):108.doi:10.1186/1477-7819-12-108.
   PubMedGoogle Scholar
• Tripathi R, Chen Z, Li L, Bordeaux JS. Incidence and survival of sebaceous carcinoma in the United States. J Am Acad Dermatol. 2016;75(6):1210–1215. doi:10.1016/j.jaad.2016.07.046.
   PubMed Web of Science ®Google Scholar
• Thomas WW, Fritsch VA, Lentsch EJ. Population-based analysis of prognostic indicators in sebaceous carcinoma of the head and neck. Laryngoscope. 2013;123(9):2165–2169. doi:10.1002/lary.24042.
   PubMed Web of Science ®Google Scholar
• Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20–37. doi:10.1634/theoncologist.12-1-20.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FLTA. AJCC cancer staging handbook: from the ajcc cancer staging manual (7th edition). Am Jt Commitee Cancer. 20102011. doi:10.1007/s00259-010-1693-9.
   Google Scholar
• Park S-K, Park J, Kim H-U, Yun S-K. Sebaceous carcinoma: clinicopathologic analysis of 29 cases in a tertiary hospital in Korea. J Korean Med Sci. 2017;32(8):1351. doi:10.3346/jkms.2017.32.8.1351.
   PubMed Web of Science ®Google Scholar
• Wong C-Y, Tang RK-T, Lam RF, et al. Muir-torre syndrome in a middle-aged Chinese patient with sebaceous carcinoma of the eyelid. Semin Ophthalmol. 2015;30(5–6):420–422.doi:10.3109/08820538.2013.833267.
   PubMed Web of Science ®Google Scholar
• Bhadra R, Moretto MM, Castillo JC, et al. Intrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attrition. J Clin Invest. 2014;124(6):2441–2455.doi:10.1172/JCI70522.
   PubMed Web of Science ®Google Scholar
• Abdi U, Tyagi N, Maheshwari V, Gogi R, Tyagi SP. Tumours of eyelid: a clinicopathologic study. J Indian Med Assoc. 1996;94(11):405–409, 416, 418. http://www.ncbi.nlm.nih.gov/pubmed/9141864. Accessed November 19, 2017.
   PubMedGoogle Scholar
• Chee SP, Goh SH. Sebaceous carcinoma of the eyelids: a review of six cases. Ann Acad Med Singapore. 1996;25(2):273–278. http://www.ncbi.nlm.nih.gov/pubmed/8799021. Accessed November 19, 2017.
   PubMedGoogle Scholar
• Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982;22(1):23–61. http://www.ncbi.nlm.nih.gov/pubmed/7061198 Accessed November 19, 2017.
   PubMedGoogle Scholar
• Khan JA, Doane JF, Grove AS. Sebaceous and meibomian carcinomas of the eyelid. Recognition, diagnosis, and management. Ophthal Plast Reconstr Surg. 1991;7(1):61–66. http://www.ncbi.nlm.nih.gov/pubmed/2018750 Accessed November 19, 2017.
   PubMed Web of Science ®Google Scholar
• Sinard JH. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma. Arch Ophthalmol (Chicago, Ill 1960). 1999;117(6):776–783. http://www.ncbi.nlm.nih.gov/pubmed/10369589 Accessed July 4, 2018.
   PubMedGoogle Scholar
• Ginsberg J. PRESENT STATUS OF MEIBOMIAN GLAND CARCINOMA. Arch Ophthalmol (Chicago, Ill 1960). 1965;73:271–277. http://www.ncbi.nlm.nih.gov/pubmed/14237799 Accessed February 10, 2018.
   PubMedGoogle Scholar
• Straatsma BR. Meibomian gland tumors. AMA Arch Ophthalmol. 1956;56(1):71–93. http://www.ncbi.nlm.nih.gov/pubmed/13338927 Accessed February 10, 2018.
   PubMedGoogle Scholar
• Scheie HG, Yanoff M, Frayer WC. CARCINOMA OF SEBACEOUS GLANDS OF THE EYELID. Arch Ophthalmol (Chicago, Ill 1960). 1964;72:800–803. http://www.ncbi.nlm.nih.gov/pubmed/14205440 Accessed February 10, 2018.
   PubMedGoogle Scholar
• Choi YJ, Jin HC, Lee MJ, Kim N, Choung H-K, Khwarg SI. Prognostic value of clinical and pathologic T stages defined by the American joint committee on cancer for eyelid sebaceous carcinoma in Korea. Jpn J Ophthalmol. 2014;58(4):327–333. doi:10.1007/s10384-014-0321-9.
   PubMed Web of Science ®Google Scholar
• Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982;13(2):113–122. http://www.ncbi.nlm.nih.gov/pubmed/7076199 Accessed February 12, 2018.
   PubMed Web of Science ®Google Scholar
• Zürcher M, Hintschich CR, Garner A, Bunce C, Collin JR. Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol. 1998;82(9):1049–1055. http://www.ncbi.nlm.nih.gov/pubmed/9893597 Accessed February 10, 2018.
   PubMed Web of Science ®Google Scholar
• Sawyer AR, McGoldrick RB, Mackey S, Powell B, Pohl M. Should extraocular sebaceous carcinoma be investigated using sentinel node biopsy? Dermatol Surg. 2009;35(4):704–708. http://www.ncbi.nlm.nih.gov/pubmed/19415798 Accessed February 10, 2018.
   PubMed Web of Science ®Google Scholar
• Cook BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2088–98; quiz 2099–100, 2121. http://www.ncbi.nlm.nih.gov/pubmed/11713084 Accessed February 12, 2018.
   Web of Science ®Google Scholar
• Folberg R, Whitaker DC, Tse DT, Nerad JA. Recurrent and residual sebaceous carcinoma after Mohs’ excision of the primary lesion. Am J Ophthalmol. 1987;103(6):817–823. http://www.ncbi.nlm.nih.gov/pubmed/3591880 Accessed February 12, 2018.
   PubMed Web of Science ®Google Scholar
• Tenzel RR, Stewart WB, Boynton JR, Zbar M. Sebaceous adenocarcinoma of the eyelid. Definition of surgical margins. Arch Ophthalmol (Chicago, Ill 1960). 1977;95(12):2203–2204. http://www.ncbi.nlm.nih.gov/pubmed/588115 Accessed February 12, 2018.
   PubMedGoogle Scholar
• Harvey JT, Anderson RL. The management of meibomian gland carcinoma. Ophthalmic Surg. 1982;13(1):56–61. http://www.ncbi.nlm.nih.gov/pubmed/7058051. Accessed February 13, 2018.
   PubMedGoogle Scholar
• Hendley RL, Rieser JC, Cavanagh HD, Bodner BI, Waring GO. Primary radiation therapy for meibomian gland carcinoma. Am J Ophthalmol. 1979;87(2):206–209. http://www.ncbi.nlm.nih.gov/pubmed/434074 Accessed February 13, 2018.
   PubMed Web of Science ®Google Scholar
• Maniglia AJ. Meibomian gland adenocarcinoma of the eyelid with neck metastasis. Laryngoscope. 1978;88(9 Pt 1):1421–1426. http://www.ncbi.nlm.nih.gov/pubmed/682799 Accessed February 13, 2018.
   PubMed Web of Science ®Google Scholar
• Yen MT, Tse DT, Wu X, Wolfson AH. Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature. Ophthal Plast Reconstr Surg. 2000;16(3):211–215. http://www.ncbi.nlm.nih.gov/pubmed/10826762 Accessed February 13, 2018.
   PubMed Web of Science ®Google Scholar
• Pardo FS, Borodic G. Long-term follow-up of patients undergoing definitive radiation therapy for sebaceous carcinoma of the ocular adnexae. Int J Radiat Oncol Biol Phys. 1996;34(5):1189–1190. http://www.ncbi.nlm.nih.gov/pubmed/8600110 Accessed February 13, 2018.
   PubMed Web of Science ®Google Scholar
• Nunery WR, Welsh MG, McCord CD. Recurrence of sebaceous carcinoma of the eyelid after radiation therapy. Am J Ophthalmol. 1983;96(1):10–15. http://www.ncbi.nlm.nih.gov/pubmed/6869463 Accessed February 13, 2018.
   PubMed Web of Science ®Google Scholar
• Matsumoto CS, Nakatsuka K, Matsuo K, Yatsuka H, Monzen Y. Sebaceous carcinoma responds to radiation therapy. Ophthalmologica. 1995;209(5):280–283. http://www.ncbi.nlm.nih.gov/pubmed/8570154. Accessed February 13, 2018.
   PubMed Web of Science ®Google Scholar
• Lee IJ, Lee RJ, Fahim DK. Prognostic factors and survival outcome in patients with chordoma in the United States: a population-based analysis. World Neurosurg. 2017;104:346–355.
   PubMed Web of Science ®Google Scholar
• Koyama S, Honda T, Hayano T, et al. [A case of lung metastasis from Meibomian gland carcinoma of eyelid with effective chemotherapy]. Gan To Kagaku Ryoho. 1994;21(16):2809–2812. http://www.ncbi.nlm.nih.gov/pubmed/7993118 Accessed February 13, 2018.
   PubMedGoogle Scholar
• Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50(2):103–122. doi:10.1016/j.survophthal.2004.12.008.
   PubMed Web of Science ®Google Scholar